People diagnosed with type 2 diabetes before age 40 face a higher lifetime risk of heart and kidney problems, so may benefit from adding another type of medicine called a GLP-1 receptor agonist (such ...

NICE recommends SGLT-2 inhibitors with metformin at diagnosis, citing major cardiovascular, renal, and mortality benefits.

Most people with type 2 diabetes should be offered SGLT-2 inhibitors much earlier in their treatment, final NICE guidance has ...

Doctors should prescribe a sodium-glucose cotransporter-2 (SGLT-2) inhibitor alongside metformin to most patients with newly diagnosed type 2 diabetes, the National Institute for Health and Care ...

Statistics indicate that type 2 diabetes (T2D) affects approximately 14% of the global population. This is significant ...

New guidance from NICE recommends earlier use of SGLT-2 inhibitors and personalised treatment for people with type 2 diabetes ...

Among adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification. Objectives: To describe ...

Metformin is particularly effective for people with diabetes or prediabetes who have obesity and have difficulty managing their blood sugar through lifestyle changes alone. Metformin is a widely used ...